Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients Converted From Twice-daily Tacrolimus

NCT02953873 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT02953873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02953873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients Converted From Twice-daily Tacrolimus
Lead sponsor
Medical University of South Carolina
Phase
Phase 4
Overall status
Completed
Start date
May 5, 2017
Completion date
December 14, 2018
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunosuppression